Dr. Lisa Barroilhet
Claim this profileUniversity of Wisconsin Carbone Cancer Center
Studies Ovarian Cancer
Studies Stomach Cancer
15 reported clinical trials
28 drugs studied
Area of expertise
1Ovarian Cancer
Stage III
Stage IV
BRCA1 positive
2Stomach Cancer
Stage III
Stage IV
Stage II
Affiliated Hospitals
Clinical Trials Lisa Barroilhet is currently running
RG1-VLP Vaccine
for HPV-Related Cancers
This phase I trial tests the safety, side effects, and best dose of RG1-virus-like particle (VLP) in preventing human papillomavirus (HPV)-related cancers in women. RG1-VLP is a vaccine that aims to protect against rare HPV types not targeted by currently approved HPV vaccines. HPV is a common sexually-transmitted infection that can cause certain genital and oral cancers. RG1-VLP contains a protein of HPV type 16 (HPV16) with a slightly different structure than the licensed Gardasil-9 vaccine. Gardasil-9 is approved by the Federal Drug Administration to help protect against diseases caused by some types of HPV. Gardasil-9 also contains 9 different HPV proteins. Both vaccines contain alum to stimulate the immune system. The usual approach for the prevention of HPV-related cancers for patients who are at increased risk is to consider the currently approved HPV vaccine like Gardasil-9, as well as to be followed closely by their doctor to watch for the development of cancer via routine pap smears. This trial may allow researchers to find out whether the RG1-VLP vaccine can safely trigger an immune response against HPV in healthy women and if it is better or worse than the usual approach for the prevention of HPV-related cancers.
Recruiting0 awards Phase 1
Letrozole +/- Chemotherapy
for Ovarian Cancer
This phase III trial studies how well letrozole with or without paclitaxel and carboplatin works in treating patients with stage II-IV low-grade serous carcinoma of the ovary, fallopian tube, or peritoneum. Letrozole is an enzyme inhibitor that lowers the amount of estrogen made by the body which in turn may stop the growth of tumor cells that need estrogen to grow. Drugs used in chemotherapy, such as paclitaxel and carboplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. It is not yet known whether giving letrozole alone or in combination with paclitaxel and carboplatin works better in treating patients with low-grade serous carcinoma of the ovary, fallopian tube, or peritoneum compared to paclitaxel and carboplatin without letrozole.
Recruiting2 awards Phase 318 criteria
More about Lisa Barroilhet
Clinical Trial Related5 years of experience running clinical trials · Led 15 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Lisa Barroilhet has experience with
- Pegylated Liposomal Doxorubicin Hydrochloride
- Paclitaxel
- Laparotomy
- Chemotherapy
- Minimally Invasive Surgery
- RG1-VLP Vaccine
Breakdown of trials Lisa Barroilhet has run
Ovarian Cancer
Stomach Cancer
Ovarian Carcinoma
Skin Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Lisa Barroilhet specialize in?
Lisa Barroilhet focuses on Ovarian Cancer and Stomach Cancer. In particular, much of their work with Ovarian Cancer has involved Stage III patients, or patients who are Stage IV.
Is Lisa Barroilhet currently recruiting for clinical trials?
Yes, Lisa Barroilhet is currently recruiting for 4 clinical trials in Madison Wisconsin. If you're interested in participating, you should apply.
Are there any treatments that Lisa Barroilhet has studied deeply?
Yes, Lisa Barroilhet has studied treatments such as Pegylated Liposomal Doxorubicin Hydrochloride, Paclitaxel, Laparotomy.
What is the best way to schedule an appointment with Lisa Barroilhet?
Apply for one of the trials that Lisa Barroilhet is conducting.
What is the office address of Lisa Barroilhet?
The office of Lisa Barroilhet is located at: University of Wisconsin Carbone Cancer Center, Madison, Wisconsin 53792 United States. This is the address for their practice at the University of Wisconsin Carbone Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.